Item 2.02 Results of Operations and Financial Condition.
On January 13, 2022, spokespersons of ViewRay, Inc. ("ViewRay" or the "Company")
plan to present the information in the presentation attached hereto as Exhibit
99.1 to analysts and investors which will include its preliminary financial
results for the fourth quarter and full fiscal year ended December 31, 2021.
The information in this Item 2.02 of this Current Report on Form 8-K and the
Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section
18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
otherwise subject to the liabilities of that Section or Sections 11 and 12(a)(2)
of the Securities Act of 1933, as amended (the "Securities Act"), or
incorporated by reference in any filing of ViewRay under the Securities Act or
the Exchange Act, whether made before or after the date hereof, regardless of
any general incorporation language in such filing.
Item 7.01 Regulation FD Disclosure.
Spokespersons of ViewRay plan to present the information in the presentation
attached hereto as Exhibit 99.1 to analysts and investors from time to time on
or after January 13, 2022. The presentation will be available on the Investor
Relations page at Company's website at: http://investors.viewray.com.
The furnishing of the attached presentation is not an admission as to the
materiality of any information therein. The information contained in the
presentation is summary information that is intended to be considered in the
context of more complete information included in ViewRay's filings with the U.S.
Securities and Exchange Commission (the "SEC") and other public announcements
that ViewRay has made and may make from time to time by press release or
otherwise. ViewRay undertakes no duty or obligation to update or revise the
information contained in this report, although it may do so from time to time as
its management believes is appropriate. Any such updating may be made through
the filing of other reports or documents with the SEC, through press releases or
through other public disclosures. For important information about forward
looking statements, see the slide titled "Forward-Looking Statements &
Disclaimer" in Exhibit 99.1 attached hereto.
The information in this Item 7.01 of this Current Report on Form 8-K and the
Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section
18 of the Exchange Act, or otherwise subject to the liabilities of that Section
or Sections 11 and 12(a)(2) of the Securities Act, or incorporated by reference
in any filing of the Company under the Securities Act or the Exchange Act,
whether made before or after the date hereof, regardless of any general
incorporation language in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number               Description
                  99.1         ViewRay J.P. Morgan Healthcare Conference Presentation.
                   104       Cover Page Interactive Data File (embedded

within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses